|
⚲
|
| Keyboard |
| Bhatt Nailesh
✚
|
|
|---|---|
| CIK # | 0001806525 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001806525] | |
| 4 | [0001806525] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hyperliquid Strategies Inc | |
| Bhatt Nailesh | |
| Sonnet BioTherapeutics Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Hyperliquid Strategies Inc PURR
Common Stock
|
2026-02-09 | Grant | 40,789 | $0.00 | |
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2025-12-02 | Disposed to issuer | 10,547 | ||
|
Hyperliquid Strategies Inc PURR
Common Stock
|
2025-12-02 | Other | 2,082 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2025-07-11 | Grant | 10,000 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2023-12-11 | Grant | 373 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2023-05-17 | Buy | 25,000 | $0.23 | 5,750 |
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2022-12-14 | Grant | 3,770 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2021-12-15 | Grant | 14,152 | ||
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2020-07-02 | Grant | 8,005 | $0.00 | |
|
Sonnet BioTherapeutics Holdings Inc SONN
Common Stock
|
2020-04-01 | Grant | 5,328 |